home / stock / ntgn / ntgn news


NTGN News and Press, Neon Therapeutics Inc.

Stock Information

Company Name: Neon Therapeutics Inc.
Stock Symbol: NTGN
Market: NASDAQ
Website: neontherapeutics.com

Menu

NTGN NTGN Quote NTGN Short NTGN News NTGN Articles NTGN Message Board
Get NTGN Alerts

News, Short Squeeze, Breakout and More Instantly...

NTGN - Achilles Therapeutics Aims For $176 Million U.S. IPO

Achilles Therapeutics has filed proposed terms for a $176 million U.S. IPO. The firm is developing treatment candidates for various cancers. ACHL won't have data readout until the second half of 2022 for its Phase 1 safety trials, so the IPO may be more suited to institutional inv...

NTGN - IPO Update: CureVac Readies Plans For U.S. IPO

Quick Take CureVac ( CVAC ) intends to raise $200 million from the sale of its common stock in an IPO, plus another $118 million from a concurrent private placement, according to an amended registration statement . The company is advancing a number of drug development and gene therapy pro...

NTGN - CureVac Starts U.S. IPO Effort

Quick Take CureVac B.V. ( CVAC ) has filed to raise $100 million in an IPO of its common shares, according to an F-1 registration statement . The firm is developing a wide range of treatments, vaccines and therapies based on messenger RNA technologies. CVAC has developed extensive colla...

NTGN - Merger Arbitrage Mondays - 3 New Deals, 4 Completions And 1 Failed Deal

Merger activity increased last week with three new deals announced, four deals closing and one deal terminated. After a three-week lull, merger activity picked up again with three new deals announced. The hard-hit energy services industry saw the merger of KLX Energy Services Holdings (KLX...

NTGN - Neon Therapeutics Announces Acceptance of European Clinical Trial Authorization Application for NEO-PTC-01

CAMBRIDGE, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN) today announced the acceptance of its Clinical Trial Authorization (CTA) from the Dutch Health Authority (DHA) for its personal neoantigen-targeted T cell therapy candidate, NEO-PTC-01. Neon...

NTGN - Merger Arbitrage Mondays - Spread On The Taubman Centers Acquisition Exceeds 40%

Merger activity continued to remain lackluster last week with no new deals announced and one deal closing. This is the second time in a row no new deals were announced. FSB Bancorp ( FSBC ), Forescout Technologies ( FSCT ), IBERIABANK Corporation ( IBKC ), and The Stars Group ( TSG ) receive...

NTGN - CMG, CLDX among premarket gainers

SAExploration Holdings (NASDAQ: SAEX ) +177%  on $27M new project in Greece. More news on: SAExploration Holdings, Inc., B.O.S. Better Online Solutions Ltd., The Peck Company Holdings, Inc., Stocks on the move, Read more ...

NTGN - Neon Therapeutics up 32% on planned tie-up with BioNTech

Nano cap Neon Therapeutics (NASDAQ: NTGN ) jumps  32%  premarket on increased volume in reaction to its all-stock merger agreement with BioNTech (NASDAQ: BNTX ). At closing, NTGN shareholders will receive 0.063 of a BNTX ADS, each whole ADS representing one BNTX ordinary share, f...

NTGN - Merger Arbitrage Mondays - 7 Deals Close But Spreads Remain Wide

Merger activity increased last week with one new deal announced and seven deals closing. At a time when more than 10 deals trade with spreads of over 30% and 23 trade with spreads of over 10%, it is encouraging to see so many deals close including the acquisition of Sprint by T-Mobile (TMUS). ...

NTGN - Are Shareholders Getting a Fair Deal? Halper Sadeh LLP Investigates the Sale of These Companies - NTGN, FSB, OPB

NEW YORK, NY / ACCESSWIRE / April 7, 2020 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate whether the following proposed mergers are fair to shareholders. Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the ...

Next 10